Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Assets (2020 - 2025)

Historic Return on Assets for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 0.13%.

  • Legend Biotech's Return on Assets fell 900.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.09% for FY2024, which is 900.0% down from last year.
  • As of Q3 2025, Legend Biotech's Return on Assets stood at 0.13%, which was down 900.0% from 0.18% recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Return on Assets ranged from a high of 0.0% in Q2 2021 and a low of 0.64% during Q4 2021
  • Moreover, its 5-year median value for Return on Assets was 0.12% (2025), whereas its average is 0.19%.
  • As far as peak fluctuations go, Legend Biotech's Return on Assets tumbled by -6400bps in 2021, and later soared by 3300bps in 2024.
  • Over the past 5 years, Legend Biotech's Return on Assets (Quarter) stood at 0.64% in 2021, then rose by 6bps to 0.6% in 2022, then soared by 66bps to 0.2% in 2023, then skyrocketed by 90bps to 0.02% in 2024, then tumbled by -549bps to 0.13% in 2025.
  • Its Return on Assets stands at 0.13% for Q3 2025, versus 0.18% for Q2 2025 and 0.12% for Q1 2025.